John Geigert

2013

Preparing the 2nd edition of my book was a humbling experience for me. My primary purpose for updating the 1st edition was to continue to provide relevant insight and practical suggestions for a risk-managed, common sense, scientific, practical business approach to managing the Chemistry, Manufacturing and Controls (CMC) regulatory compliance requirements and expectations for biopharmaceuticals as human medicinal products.